FBTIX vs. XBI
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund I Class (FBTIX) and SPDR S&P Biotech ETF (XBI).
FBTIX is managed by Fidelity. It was launched on Dec 27, 2000. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Performance
FBTIX vs. XBI - Performance Comparison
Loading graphics...
FBTIX vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBTIX Fidelity Advisor Biotechnology Fund I Class | -2.62% | 39.91% | 5.63% | 11.02% | -7.74% | -2.86% | 32.53% | 26.11% | -3.61% | 26.15% |
XBI SPDR S&P Biotech ETF | 4.76% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Returns By Period
In the year-to-date period, FBTIX achieves a -2.62% return, which is significantly lower than XBI's 4.76% return. Over the past 10 years, FBTIX has outperformed XBI with an annualized return of 11.60%, while XBI has yielded a comparatively lower 9.32% annualized return.
FBTIX
- 1D
- -0.74%
- 1M
- -6.04%
- YTD
- -2.62%
- 6M
- 11.57%
- 1Y
- 43.10%
- 3Y*
- 18.79%
- 5Y*
- 8.22%
- 10Y*
- 11.60%
XBI
- 1D
- 7.53%
- 1M
- 0.28%
- YTD
- 4.76%
- 6M
- 27.90%
- 1Y
- 58.08%
- 3Y*
- 19.00%
- 5Y*
- -1.29%
- 10Y*
- 9.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTIX vs. XBI - Expense Ratio Comparison
FBTIX has a 0.73% expense ratio, which is higher than XBI's 0.35% expense ratio.
Return for Risk
FBTIX vs. XBI — Risk / Return Rank
FBTIX
XBI
FBTIX vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund I Class (FBTIX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTIX | XBI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.58 | 2.02 | -0.44 |
Sortino ratioReturn per unit of downside risk | 2.12 | 2.70 | -0.58 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.34 | -0.07 |
Calmar ratioReturn relative to maximum drawdown | 2.40 | 3.72 | -1.32 |
Martin ratioReturn relative to average drawdown | 9.76 | 13.98 | -4.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBTIX | XBI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.58 | 2.02 | -0.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.36 | -0.04 | +0.40 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | 0.29 | +0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.36 | -0.04 |
Correlation
The correlation between FBTIX and XBI is 0.93, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBTIX vs. XBI - Dividend Comparison
FBTIX's dividend yield for the trailing twelve months is around 1.42%, more than XBI's 0.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTIX Fidelity Advisor Biotechnology Fund I Class | 1.42% | 1.39% | 5.69% | 1.36% | 0.00% | 18.74% | 8.01% | 6.44% | 2.35% | 0.00% | 0.00% | 5.23% |
XBI SPDR S&P Biotech ETF | 0.34% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Drawdowns
FBTIX vs. XBI - Drawdown Comparison
The maximum FBTIX drawdown since its inception was -63.45%, roughly equal to the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for FBTIX and XBI.
Loading graphics...
Drawdown Indicators
| FBTIX | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.45% | -63.89% | +0.44% |
Max Drawdown (1Y)Largest decline over 1 year | -13.62% | -13.39% | -0.23% |
Max Drawdown (5Y)Largest decline over 5 years | -36.41% | -55.04% | +18.63% |
Max Drawdown (10Y)Largest decline over 10 years | -38.64% | -63.89% | +25.25% |
Current DrawdownCurrent decline from peak | -7.21% | -26.17% | +18.96% |
Average DrawdownAverage peak-to-trough decline | -20.73% | -20.91% | +0.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.09% | 3.71% | +0.38% |
Volatility
FBTIX vs. XBI - Volatility Comparison
The current volatility for Fidelity Advisor Biotechnology Fund I Class (FBTIX) is 7.77%, while SPDR S&P Biotech ETF (XBI) has a volatility of 11.60%. This indicates that FBTIX experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBTIX | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.77% | 11.60% | -3.83% |
Volatility (6M)Calculated over the trailing 6-month period | 16.36% | 19.25% | -2.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.57% | 29.24% | -3.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.23% | 32.23% | -9.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.54% | 32.15% | -7.61% |